AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.
Related Posts
Buy American to avoid Trump trade war, says Lagarde
- admin
- November 28, 2024
- 0
ECB chief takes aim at claim that tariffs will ‘make America great again’ — but calls for negotiation, not retaliation
A+E Networks Settles ‘Live PD’ Copyright Suit as Part of Amazon Deal
- admin
- November 22, 2024
- 0
The agreement includes a multi-year licensing deal for A&E programs and the launch of additional FAST channels on Prime Video.
Condé Nast Undergoes New Round of Layoffs
- admin
- December 5, 2024
- 0
Under CEO Roger Lynch, the magazine giant continues to make changes to its portfolio in a challenged media environment.